[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Contract Pharmaceutical Manufacturing Market Report 2017

January 2017 | 106 pages | ID: U7165053F88EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Contract Pharmaceutical Manufacturing

Revenue, means the sales value of Contract Pharmaceutical Manufacturing

This report studies sales (consumption) of Contract Pharmaceutical Manufacturing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Catalent
  • DPx
  • Lonza
  • Piramal Healthcare
  • Aenova
  • Jubilant
  • Famar
  • Boehringer Ingelheim
  • Fareva Holding
  • AbbVie
  • Nipro Corp
  • Vetter
  • Sopharma
  • DPT Laboratories
  • Recipharm
  • NextPharma
  • Dishman
  • Aesica
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Active Pharmaceutical Ingredients (API)
  • Finished Dosage Formulations (FDF)
Split by applications, this report focuses on sales, market share and growth rate of Contract Pharmaceutical Manufacturing in each application, can be divided into
  • Big Pharma
  • Specialty/Midsize
  • Generics
  • Other
United States Contract Pharmaceutical Manufacturing Market Report 2017

1 CONTRACT PHARMACEUTICAL MANUFACTURING OVERVIEW

1.1 Product Overview and Scope of Contract Pharmaceutical Manufacturing
1.2 Classification of Contract Pharmaceutical Manufacturing
  1.2.1 Active Pharmaceutical Ingredients (API)
  1.2.2 Finished Dosage Formulations (FDF)
1.3 Application of Contract Pharmaceutical Manufacturing
  1.3.1 Big Pharma
  1.3.2 Specialty/Midsize
  1.3.3 Generics
  1.3.4 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Contract Pharmaceutical Manufacturing (2011-2021)
  1.4.1 United States Contract Pharmaceutical Manufacturing Sales and Growth Rate (2011-2021)
  1.4.2 United States Contract Pharmaceutical Manufacturing Revenue and Growth Rate (2011-2021)

2 UNITED STATES CONTRACT PHARMACEUTICAL MANUFACTURING COMPETITION BY MANUFACTURERS

2.1 United States Contract Pharmaceutical Manufacturing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Contract Pharmaceutical Manufacturing Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Contract Pharmaceutical Manufacturing Average Price by Manufactures (2015 and 2016)
2.4 Contract Pharmaceutical Manufacturing Market Competitive Situation and Trends
  2.4.1 Contract Pharmaceutical Manufacturing Market Concentration Rate
  2.4.2 Contract Pharmaceutical Manufacturing Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CONTRACT PHARMACEUTICAL MANUFACTURING SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Contract Pharmaceutical Manufacturing Sales and Market Share by States (2011-2016)
3.2 United States Contract Pharmaceutical Manufacturing Revenue and Market Share by States (2011-2016)
3.3 United States Contract Pharmaceutical Manufacturing Price by States (2011-2016)

4 UNITED STATES CONTRACT PHARMACEUTICAL MANUFACTURING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Contract Pharmaceutical Manufacturing Sales and Market Share by Type (2011-2016)
4.2 United States Contract Pharmaceutical Manufacturing Revenue and Market Share by Type (2011-2016)
4.3 United States Contract Pharmaceutical Manufacturing Price by Type (2011-2016)
4.4 United States Contract Pharmaceutical Manufacturing Sales Growth Rate by Type (2011-2016)

5 UNITED STATES CONTRACT PHARMACEUTICAL MANUFACTURING SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Contract Pharmaceutical Manufacturing Sales and Market Share by Application (2011-2016)
5.2 United States Contract Pharmaceutical Manufacturing Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES CONTRACT PHARMACEUTICAL MANUFACTURING MANUFACTURERS PROFILES/ANALYSIS

6.1 Catalent
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.1.2.1 Active Pharmaceutical Ingredients (API)
    6.1.2.2 Finished Dosage Formulations (FDF)
  6.1.3 Catalent Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 DPx
  6.2.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.2.2.1 Active Pharmaceutical Ingredients (API)
    6.2.2.2 Finished Dosage Formulations (FDF)
  6.2.3 DPx Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Lonza
  6.3.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.3.2.1 Active Pharmaceutical Ingredients (API)
    6.3.2.2 Finished Dosage Formulations (FDF)
  6.3.3 Lonza Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Piramal Healthcare
  6.4.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.4.2.1 Active Pharmaceutical Ingredients (API)
    6.4.2.2 Finished Dosage Formulations (FDF)
  6.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Aenova
  6.5.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.5.2.1 Active Pharmaceutical Ingredients (API)
    6.5.2.2 Finished Dosage Formulations (FDF)
  6.5.3 Aenova Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Jubilant
  6.6.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.6.2.1 Active Pharmaceutical Ingredients (API)
    6.6.2.2 Finished Dosage Formulations (FDF)
  6.6.3 Jubilant Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Famar
  6.7.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.7.2.1 Active Pharmaceutical Ingredients (API)
    6.7.2.2 Finished Dosage Formulations (FDF)
  6.7.3 Famar Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Boehringer Ingelheim
  6.8.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.8.2.1 Active Pharmaceutical Ingredients (API)
    6.8.2.2 Finished Dosage Formulations (FDF)
  6.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Fareva Holding
  6.9.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.9.2.1 Active Pharmaceutical Ingredients (API)
    6.9.2.2 Finished Dosage Formulations (FDF)
  6.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 AbbVie
  6.10.2 Contract Pharmaceutical Manufacturing Product Type, Application and Specification
    6.10.2.1 Active Pharmaceutical Ingredients (API)
    6.10.2.2 Finished Dosage Formulations (FDF)
  6.10.3 AbbVie Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Nipro Corp
6.12 Vetter
6.13 Sopharma
6.14 DPT Laboratories
6.15 Recipharm
6.16 NextPharma
6.17 Dishman
6.18 Aesica

7 CONTRACT PHARMACEUTICAL MANUFACTURING MANUFACTURING COST ANALYSIS

7.1 Contract Pharmaceutical Manufacturing Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Contract Pharmaceutical Manufacturing

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Contract Pharmaceutical Manufacturing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Contract Pharmaceutical Manufacturing Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CONTRACT PHARMACEUTICAL MANUFACTURING MARKET FORECAST (2016-2021)

11.1 United States Contract Pharmaceutical Manufacturing Sales, Revenue Forecast (2016-2021)
11.2 United States Contract Pharmaceutical Manufacturing Sales Forecast by Type (2016-2021)
11.3 United States Contract Pharmaceutical Manufacturing Sales Forecast by Application (2016-2021)
11.4 Contract Pharmaceutical Manufacturing Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Contract Pharmaceutical Manufacturing
Table Classification of Contract Pharmaceutical Manufacturing
Figure United States Sales Market Share of Contract Pharmaceutical Manufacturing by Type in 2015
Figure Active Pharmaceutical Ingredients (API) Picture
Figure Finished Dosage Formulations (FDF) Picture
Table Application of Contract Pharmaceutical Manufacturing
Figure United States Sales Market Share of Contract Pharmaceutical Manufacturing by Application in 2015
Figure Big Pharma Examples
Figure Specialty/Midsize Examples
Figure Generics Examples
Figure Other Examples
Figure United States Contract Pharmaceutical Manufacturing Sales and Growth Rate (2011-2021)
Figure United States Contract Pharmaceutical Manufacturing Revenue and Growth Rate (2011-2021)
Table United States Contract Pharmaceutical Manufacturing Sales of Key Manufacturers (2015 and 2016)
Table United States Contract Pharmaceutical Manufacturing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Contract Pharmaceutical Manufacturing Sales Share by Manufacturers
Figure 2016 Contract Pharmaceutical Manufacturing Sales Share by Manufacturers
Table United States Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2015 and 2016)
Table United States Contract Pharmaceutical Manufacturing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Contract Pharmaceutical Manufacturing Revenue Share by Manufacturers
Table 2016 United States Contract Pharmaceutical Manufacturing Revenue Share by Manufacturers
Table United States Market Contract Pharmaceutical Manufacturing Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Contract Pharmaceutical Manufacturing Average Price of Key Manufacturers in 2015
Figure Contract Pharmaceutical Manufacturing Market Share of Top 3 Manufacturers
Figure Contract Pharmaceutical Manufacturing Market Share of Top 5 Manufacturers
Table United States Contract Pharmaceutical Manufacturing Sales by States (2011-2016)
Table United States Contract Pharmaceutical Manufacturing Sales Share by States (2011-2016)
Figure United States Contract Pharmaceutical Manufacturing Sales Market Share by States in 2015
Table United States Contract Pharmaceutical Manufacturing Revenue and Market Share by States (2011-2016)
Table United States Contract Pharmaceutical Manufacturing Revenue Share by States (2011-2016)
Figure Revenue Market Share of Contract Pharmaceutical Manufacturing by States (2011-2016)
Table United States Contract Pharmaceutical Manufacturing Price by States (2011-2016)
Table United States Contract Pharmaceutical Manufacturing Sales by Type (2011-2016)
Table United States Contract Pharmaceutical Manufacturing Sales Share by Type (2011-2016)
Figure United States Contract Pharmaceutical Manufacturing Sales Market Share by Type in 2015
Table United States Contract Pharmaceutical Manufacturing Revenue and Market Share by Type (2011-2016)
Table United States Contract Pharmaceutical Manufacturing Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Contract Pharmaceutical Manufacturing by Type (2011-2016)
Table United States Contract Pharmaceutical Manufacturing Price by Type (2011-2016)
Figure United States Contract Pharmaceutical Manufacturing Sales Growth Rate by Type (2011-2016)
Table United States Contract Pharmaceutical Manufacturing Sales by Application (2011-2016)
Table United States Contract Pharmaceutical Manufacturing Sales Market Share by Application (2011-2016)
Figure United States Contract Pharmaceutical Manufacturing Sales Market Share by Application in 2015
Table United States Contract Pharmaceutical Manufacturing Sales Growth Rate by Application (2011-2016)
Figure United States Contract Pharmaceutical Manufacturing Sales Growth Rate by Application (2011-2016)
Table Catalent Basic Information List
Table Catalent Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Catalent Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table DPx Basic Information List
Table DPx Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Table DPx Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table Lonza Basic Information List
Table Lonza Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table Piramal Healthcare Basic Information List
Table Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Piramal Healthcare Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table Aenova Basic Information List
Table Aenova Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aenova Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table Jubilant Basic Information List
Table Jubilant Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jubilant Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table Famar Basic Information List
Table Famar Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Famar Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table Fareva Holding Basic Information List
Table Fareva Holding Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fareva Holding Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Contract Pharmaceutical Manufacturing Sales Market Share (2011-2016)
Table Nipro Corp Basic Information List
Table Vetter Basic Information List
Table Sopharma Basic Information List
Table DPT Laboratories Basic Information List
Table Recipharm Basic Information List
Table NextPharma Basic Information List
Table Dishman Basic Information List
Table Aesica Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Contract Pharmaceutical Manufacturing
Figure Manufacturing Process Analysis of Contract Pharmaceutical Manufacturing
Figure Contract Pharmaceutical Manufacturing Industrial Chain Analysis
Table Raw Materials Sources of Contract Pharmaceutical Manufacturing Major Manufacturers in 2015
Table Major Buyers of Contract Pharmaceutical Manufacturing
Table Distributors/Traders List
Figure United States Contract Pharmaceutical Manufacturing Production and Growth Rate Forecast (2016-2021)
Figure United States Contract Pharmaceutical Manufacturing Revenue and Growth Rate Forecast (2016-2021)
Table United States Contract Pharmaceutical Manufacturing Production Forecast by Type (2016-2021)
Table United States Contract Pharmaceutical Manufacturing Consumption Forecast by Application (2016-2021)
Table United States Contract Pharmaceutical Manufacturing Sales Forecast by States (2016-2021)
Table United States Contract Pharmaceutical Manufacturing Sales Share Forecast by States (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories